Skip to Content
Merck
All Photos(1)

Documents

EMU041771

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Plaur

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

ACAGCGAAAAGACCAACAGGACCATGAGTTACCGCATGGGCTCCATGATCATCAGCCTGACAGAGACCGTGTGCGCCACAAACCTCTGCAACAGGCCCAGACCCGGAGCCCGAGGCCGTGCTTTCCCTCAGGGCCGTTACCTCGAGTGTGCGTCCTGCACCTCTTTGGACCAGAGCTGTGAGAGGGGCCGGGAGCAAAGCCTGCAATGCCGCTATCCTACAGAGCACTGTATTGAAGTGGTGACCCTCCAGAGCACAGAAAGGAGCTTGAAGGATGAGGACTACACCCGAGGCTGTGGCAGTCTTCCCGGATGCCCAGGCACAGCAGGTTTCCATAGCAACCAGACCTTTCACTTCCTGAAGTGTTGCAACTACACCCACTGCAATGGTGGCCCAGTTCTGGATCTTCAGAGCTTTCCACCGAATGGCTTCCAGTGTTACAGCTGTGAGGGGAACAATACCCTTGGGTGTTCCTCCGAAGAGGCGTCTCTCATCAACTGCCGGGGACCAATGAATCAGTGCCTGGTGGCTAC

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M Unseld et al.
Thrombosis and haemostasis, 114(2), 379-389 (2015-05-01)
The tumour suppressor phosphatase and tensin homologue (PTEN), mutated or lost in many human cancers, is a major regulator of angiogenesis. However, the cellular mechanism of PTEN regulation in endothelial cells so far remains elusive. Here, we characterise the urokinase
Synnøve Magnussen et al.
PloS one, 9(8), e105929-e105929 (2014-08-27)
The urokinase plasminogen activator receptor (uPAR) is associated with poor prognosis in oral squamous cell carcinoma (OSCC), and increased expression of uPAR is often found at the invasive tumour front. The aim of the current study was to elucidate the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service